Confluence Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$785K Buy
11,376
+911
+9% +$62.9K 0.01% 226
2025
Q1
$727K Buy
10,465
+191
+2% +$13.3K 0.01% 231
2024
Q4
$884K Buy
10,274
+220
+2% +$18.9K 0.01% 209
2024
Q3
$1.2M Sell
10,054
-1,210
-11% -$144K 0.02% 193
2024
Q2
$1.61M Buy
11,264
+420
+4% +$60K 0.02% 187
2024
Q1
$1.39M Sell
10,844
-72
-0.7% -$9.25K 0.02% 185
2023
Q4
$1.13M Sell
10,916
-714
-6% -$73.9K 0.02% 191
2023
Q3
$1.06M Sell
11,630
-3,764
-24% -$342K 0.02% 184
2023
Q2
$1.25M Sell
15,394
-1,900
-11% -$154K 0.02% 178
2023
Q1
$1.38M Buy
17,294
+88
+0.5% +$7K 0.02% 176
2022
Q4
$1.16M Sell
17,206
-336
-2% -$22.7K 0.02% 190
2022
Q3
$874K Sell
17,542
-1,568
-8% -$78.1K 0.01% 201
2022
Q2
$1.07M Sell
19,110
-8,354
-30% -$466K 0.02% 195
2022
Q1
$1.53M Sell
27,464
-3,818
-12% -$212K 0.02% 184
2021
Q4
$1.75M Sell
31,282
-2,182
-7% -$122K 0.02% 187
2021
Q3
$1.61M Buy
33,464
+368
+1% +$17.7K 0.02% 188
2021
Q2
$1.39M Buy
33,096
+428
+1% +$17.9K 0.02% 191
2021
Q1
$1.1M Buy
32,668
+2,118
+7% +$71.4K 0.02% 196
2020
Q4
$1.07M Sell
30,550
-11,800
-28% -$412K 0.02% 205
2020
Q3
$1.47M Sell
42,350
-1,792
-4% -$62.2K 0.02% 186
2020
Q2
$1.45M Sell
44,142
-46
-0.1% -$1.51K 0.02% 187
2020
Q1
$1.33M Buy
+44,188
New +$1.33M 0.03% 190